Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tengborn

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2002
Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia AA Lindgren, H Wadenvik, L Tengborn
Lakartidningen|December 4, 1996
[A minor trauma can cause life-threatening bleeding. Varying course in eleven patients]A Lindgren, L Stigendal, L Tengborn
Lakartidningen|November 25, 1992
[Desmopressin--an effective agent in many hemorrhagic disorders]S Lethagen, S Schulman, L Tengborn
Lakartidningen|April 8, 1987
[Hereditary thrombogenic defects in the national family registry]S Schulman, L Tengborn, L Stigendal
Gynecologic and Obstetric Investigation|January 1, 1982
Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombinM Hellgren, L Tengborn, U Abildgaard
European Journal of Vascular Surgery|June 1, 1988
Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelaeB Lindblad, L Tengborn, D Bergqvist
Thrombosis and Haemostasis|June 1, 1994
Effects of metformin and metoprolol CR on hormones and fibrinolytic variables during a hyperinsulinemic, euglycemic clamp in manK Landin, L Tengborn, U Smith
Journal of Internal Medicine|April 1, 1990
Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular diseaseK Landin, L Tengborn, U Smith
Journal of Internal Medicine|April 1, 1994
Metformin and metoprolol CR treatment in non-obese menK Landin, L Tengborn, U Smith
Journal of Internal Medicine|February 1, 1991
Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factorsK Landin, L Tengborn, U Smith
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2002
Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia AA Lindgren, H Wadenvik, L Tengborn
Lakartidningen|December 4, 1996
[A minor trauma can cause life-threatening bleeding. Varying course in eleven patients]A Lindgren, L Stigendal, L Tengborn
Lakartidningen|November 25, 1992
[Desmopressin--an effective agent in many hemorrhagic disorders]S Lethagen, S Schulman, L Tengborn
Lakartidningen|April 8, 1987
[Hereditary thrombogenic defects in the national family registry]S Schulman, L Tengborn, L Stigendal
Gynecologic and Obstetric Investigation|January 1, 1982
Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombinM Hellgren, L Tengborn, U Abildgaard
European Journal of Vascular Surgery|June 1, 1988
Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelaeB Lindblad, L Tengborn, D Bergqvist
Thrombosis and Haemostasis|June 1, 1994
Effects of metformin and metoprolol CR on hormones and fibrinolytic variables during a hyperinsulinemic, euglycemic clamp in manK Landin, L Tengborn, U Smith
Journal of Internal Medicine|April 1, 1990
Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular diseaseK Landin, L Tengborn, U Smith
Journal of Internal Medicine|April 1, 1994
Metformin and metoprolol CR treatment in non-obese menK Landin, L Tengborn, U Smith
Journal of Internal Medicine|February 1, 1991
Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factorsK Landin, L Tengborn, U Smith
Pageof 10